m+Medelevator.RU
← Поиск публикаций
Journal of visualized experiments : JoVE · 2026

A Microcarrier Bead-Based Three-Dimensional Angiogenesis Model Using Human Umbilical Vein Endothelial Cells.

СтатьяVideo-Audio MediaПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Lin Jian, Zhu Ying, Chen Yin, Zhou Xingkai, Ye Ting, Wu Yibo, Wu Shuang, Yang Shu, He Yang, Li Yongsheng

Аннотация

Angiogenesis is a multistep biological process involving endothelial cell activation, migration, elongation, lumen formation, branching, and anastomosis. Conventional two-dimensional culture systems are useful for the preliminary evaluation of drugs, genes, or culture conditions, but they do not adequately recapitulate the spatial organization of endothelial morphogenesis within a three-dimensional extracellular matrix. The present protocol describes a microcarrier bead-based three-dimensional angiogenesis assay using human umbilical vein endothelial cells (HUVECs). The HUVECs are first seeded onto microcarrier beads bearing chemically coupled acid-denatured porcine type I collagen and then embedded in a basement membrane matrix. Oral mucosal fibroblasts are subsequently seeded on top of the gel to provide paracrine support for endothelial sprouting and vascular-like structure formation. The culture medium is replaced every 2 days, and sprouting behavior and angiogenic phenotypes are monitored by inverted microscopy. Under appropriate culture conditions, endothelial sprouts emerge within several days, followed by the formation of lumen-like structures and inter-sprout connections. This method provides a convenient and reproducible platform for in vitro studies of endothelial morphogenesis and can be further applied to investigations of gene manipulation, pharmacological intervention, and disease modeling.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты